Business Description
Tiziana Life Sciences Ltd
ISIN : BMG889121031
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 18.69 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -15.1 | |||||
3-Year EPS without NRI Growth Rate | -14.2 | |||||
3-Year FCF Growth Rate | -40.2 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 88.79 | |||||
9-Day RSI | 82.8 | |||||
14-Day RSI | 77.37 | |||||
6-1 Month Momentum % | -27.46 | |||||
12-1 Month Momentum % | -55.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.85 | |||||
Quick Ratio | 3.85 | |||||
Cash Ratio | 1.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.8 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -93.29 | |||||
ROA % | -74.04 | |||||
ROIC % | -443.41 | |||||
ROC (Joel Greenblatt) % | -7764.54 | |||||
ROCE % | -92.6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 5.96 | |||||
Price-to-Tangible-Book | 5.96 | |||||
EV-to-EBIT | -3.56 | |||||
EV-to-EBITDA | -3.58 | |||||
EV-to-FCF | -3.63 | |||||
Price-to-Net-Current-Asset-Value | 7.05 | |||||
Price-to-Net-Cash | 38.75 | |||||
Earnings Yield (Greenblatt) % | -28.09 | |||||
FCF Yield % | -24.56 |